Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

A Study of Oral Desmopressin in Previously Untreated Children Aged 5 to 15 Years With Primary Nocturnal Enuresis (DRIP)

This study has been completed.
Information provided by:
Ferring Pharmaceuticals Identifier:
First received: September 13, 2005
Last updated: May 18, 2011
Last verified: May 2011